(Q37826807)

23 August 2017

title

Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status (English)

1 reference

inflammatory bowel diseases

23 August 2017

main subject

0 references

0 references

1 reference

Daniel R van Langenberg

2

0 references

Gerald J. Holtmann

3

0 references

author name string

Robert V Bryant

1

1 reference

23 August 2017

Jane M Andrews

4

1 reference

23 August 2017

publication date

1 May 2011

1 reference

Journal of Gastroenterology and Hepatology

23 August 2017

published in

1 reference

23 August 2017

volume

26

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

916-923

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

23 August 2017

1 reference

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Psychiatric illness in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Symptoms of irritable bowel syndrome in ulcerative colitis in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Functional bowel disorders in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

The functional gastrointestinal disorders and the Rome III process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

21 January 2018

Irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Visceral hypersensitivity in non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Review article: Crohn's disease: monitoring disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

A simple index of Crohn's-disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Irritable bowel syndrome: a little understood organic bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Psychological stress in IBD: new insights into pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Stress, inflammation and the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Quality of life in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Updates on treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06624.X

10.1111/J.1440-1746.2011.06624.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference